Level Biotechnology Inc. (TPEX:3118)

Level Biotechnology Revenue

Level Biotechnology had revenue of 200.13M TWD in the quarter ending September 30, 2025, with 9.82% growth. This brings the company's revenue in the last twelve months to 753.30M, up 5.20% year-over-year. In the year 2024, Level Biotechnology had annual revenue of 731.35M with 10.71% growth.

• Revenue (ttm): 753.30M
• Revenue Growth: +5.20%
• P/S Ratio: 1.41
• Revenue / Employee: 5.71M
• Employees: 132
• Market Cap: 1.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	731.35M	70.74M	10.71%
Dec 31, 2023	660.61M	67.60M	11.40%
Dec 31, 2022	593.01M	-84.27M	-12.44%
Dec 31, 2021	677.28M	4.79M	0.71%
Dec 31, 2020	672.49M	33.59M	5.26%